{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T14:29:44Z","timestamp":1792506584052,"version":"4.5.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,31]],"date-time":"2021-03-31T00:00:00Z","timestamp":1617148800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["522008004"],"award-info":[{"award-number":["522008004"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.cmi.2021.03.016","type":"journal-article","created":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T22:08:05Z","timestamp":1617314885000},"page":"1273-1278","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["The prognostic value of serological titres for clinical outcomes during treatment and follow-up of patients with chronic Q fever"],"prefix":"10.1016","volume":"27","author":[{"given":"Sheila B.","family":"Buijs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja E.","family":"van Roeden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelis H.","family":"van Werkhoven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andy I.M.","family":"Hoepelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter C.","family":"Wever","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal P.","family":"Bleeker-Rovers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Jelrik","family":"Oosterheert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2021.03.016_bib1","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1128\/CMR.12.4.518","article-title":"Q\u00a0fever","volume":"12","author":"Maurin","year":"1999","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.cmi.2021.03.016_bib2","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1093\/cid\/cix886","article-title":"Treatment of chronic Q fever: clinical efficacy and toxicity of antibiotic regimens","volume":"66","author":"van Roeden","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2021.03.016_bib3","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S1473-3099(10)70135-3","article-title":"Long-term outcome of Q fever endocarditis: a 26-year personal survey","volume":"10","author":"Million","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2021.03.016_bib4","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1128\/CMR.00045-16","article-title":"From Q fever to Coxiella burnetii infection: a paradigm change","volume":"30","author":"Eldin","year":"2017","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.cmi.2021.03.016_bib5","first-page":"41","article-title":"Guidance for treatment of chronic Q fever","volume":"13","author":"van Roeden","year":"2018","journal-title":"Tijdschr Infect"},{"key":"10.1016\/j.cmi.2021.03.016_bib6","author":"Anderson"},{"key":"10.1016\/j.cmi.2021.03.016_bib7","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1016\/j.cmi.2018.11.023","article-title":"Chronic Q fever-related complications and mortality: data from a nationwide cohort","volume":"25","author":"van Roeden","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2021.03.016_bib8","series-title":"Still new chronic Q fever cases diagnosed more than five years after a large Q fever outbreak","author":"Buijs","year":"2019"},{"key":"10.1016\/j.cmi.2021.03.016_bib9","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1128\/IAI.01767-06","article-title":"T\u00a0cells are essential for bacterial clearance, and gamma interferon, tumor necrosis factor alpha, and B cells are crucial for disease development in Coxiella burnetii infection in mice","volume":"75","author":"Andoh","year":"2007","journal-title":"Infect Immun"},{"key":"10.1016\/j.cmi.2021.03.016_bib10","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1128\/IAI.00101-10","article-title":"Role of CD4+ and CD8+ T cells in clearance of primary pulmonary infection with Coxiella burnetii","volume":"78","author":"Read","year":"2010","journal-title":"Infect Immun"},{"key":"10.1016\/j.cmi.2021.03.016_bib11","first-page":"247","article-title":"Chronic Q fever: review of the literature and a proposal of new diagnostic criteria","volume":"64","author":"Wegdam-Blans","year":"2012","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.cmi.2021.03.016_bib12","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1128\/CVI.00454-09","article-title":"Real-time PCR with serum samples is indispensable for early diagnosis of acute Q fever","volume":"17","author":"Schneeberger","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.cmi.2021.03.016_bib13","doi-asserted-by":"crossref","first-page":"121","DOI":"10.21037\/atm.2018.02.12","article-title":"Time-varying covariates and coefficients in Cox regression models","volume":"6","author":"Zhang","year":"2018","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.cmi.2021.03.016_bib14","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1093\/jac\/dkx487","article-title":"The effect of measuring serum doxycycline concentrations on clinical outcomes during treatment of chronic Q fever","volume":"73","author":"van Roeden","year":"2018","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2021.03.016_bib15","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1128\/JCM.03221-13","article-title":"Chronic Q fever in the Netherlands 5 years after the start of the Q fever epidemic: results from the Dutch chronic Q fever database","volume":"52","author":"Kampschreur","year":"2014","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.cmi.2021.03.016_bib16","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1128\/CVI.05724-11","article-title":"Microbiological challenges in the diagnosis of chronic Q fever","volume":"19","author":"Kampschreur","year":"2012","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.cmi.2021.03.016_bib17","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/j.cmi.2019.02.021","article-title":"Re: chronic Q-fever-related complications and mortality: data from a nationwide cohort","volume":"25","author":"Melenotte","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2021.03.016_bib18","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/j.cmi.2019.03.004","article-title":"Chronic Q fever-related complications and mortality: data from a nationwide cohort' \u2013 author's reply","volume":"25","author":"van Roeden","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2021.03.016_bib19","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.medmal.2019.05.001","article-title":"Lyme borreliosis and other tick-borne diseases. Guidelines from the French scientific societies (II). Biological diagnosis, treatment, persistent symptoms after documented or suspected Lyme borreliosis","volume":"49","author":"Jaulhac","year":"2019","journal-title":"Med Mal Infect"},{"key":"10.1016\/j.cmi.2021.03.016_bib20","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1001\/jama.2014.13259","article-title":"Treatment of syphilis: a systematic review","volume":"312","author":"Clement","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.cmi.2021.03.016_bib21","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3389\/fmicb.2015.00093","article-title":"Specific in\u00a0vitro interferon-gamma and IL-2 production as biomarkers during treatment of chronic Q fever","volume":"6","author":"Schoffelen","year":"2015","journal-title":"Front Microbiol"},{"key":"10.1016\/j.cmi.2021.03.016_bib22","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/imr.12269","article-title":"The human immune response to tuberculosis and its treatment: a view from the blood","volume":"264","author":"Cliff","year":"2015","journal-title":"Immunol Rev"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X21001518?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X21001518?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:29:41Z","timestamp":1761118181000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X21001518"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":22,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S1198743X21001518"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2021.03.016","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The prognostic value of serological titres for clinical outcomes during treatment and follow-up of patients with chronic Q fever","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2021.03.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases.","name":"copyright","label":"Copyright"}]}}